Article Text

Download PDFPDF

An observational study of PM10 and hospital admissions for acute exacerbations of chronic respiratory disease in Tasmania, Australia 1992–2002
  1. D Mészáros1,
  2. J Markos2,
  3. D G FitzGerald3,
  4. E H Walters1 and
  5. R Wood-Baker1
  1. 1School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
  2. 2Department of Respiratory Medicine, Launceston General Hospital, Launceston, Tasmania, Australia
  3. 3School of Physical Sciences, University of Tasmania, Hobart, Tasmania, Australia
  1. Correspondence to Dr R Wood-Baker; Richard.Woodbaker{at}


Objective Particulate matter with a diameter below 10 µ (PM10) has been a major concern in the Tamar Valley, Launceston, where wood heaters are extensively used. We examined the relationship between PM10 levels, meteorological variables, respiratory medications and hospital admissions for respiratory disease over the decade 1992–2002.

Methods PM10 levels were provided by the Department of Primary Industry Water, Parks and Environment, and meteorological variables from the Bureau of Meteorology. We obtained hospital discharge codes for the Launceston General Hospital. Poisson regression was used for statistical analyses.

Results Mean daily PM10 levels declined from 50.7 to 16.5 μg/m3. Hospitalisations for asthma decreased from 29 to 21 per month, whereas chronic obstructive pulmonary disease (COPD) increased and bronchitis/bronchiolitis remained unchanged. We found a 10 μg/m3 increase in PM10 to be associated with a 4% increase in admissions for acute bronchitis/bronchiolitis (p0.05), but no association with asthma or COPD was found. All respiratory diseases showed seasonal patterns of hospitalisation.

Conclusions This is the first long-term study in Australia to demonstrate an association between PM10 levels and respiratory diseases. Reducing exposure to PM10 may decrease hospital admissions for respiratory diseases.

Implication Better preventive measures, including sustained public health initiatives to combat air pollution, are required to reduce respiratory morbidity.

  • Asthma
  • COPD epidemiology
  • COPD Exacerbations

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.